the aid library

LIST OPTIONS

Filter

2435

Sort by:

Direction:

Download (60)

View PDF (60)

Global action plan on physical activity 2018–2030: more active people for a healthier world

World Health Organisation WHO (2018) C_WHO

Regular physical activity is proven to help prevent and treat noncommunicable diseases (NCDs) such as heart disease, stroke, diabetes and breast and colon cancer. It also helps to prevent hypertension, overweight and obesity and can improve mental health, quality of life and well-being.

Download (74)

View PDF (329)

IRC Health Strategy 2023-2027

International Rescue Committee (2023) CC

The International Rescue Committee (IRC) is a leading humanitarian agency dedicated to helping people whose lives have been shattered by conflict and disaster to survive, recover, and gain control of their future. Health comprises nearly half of IRC’s program portfolio globally and encompasses thr... more

Download (489)

View PDF (521)

Integrating neglected tropical diseases in global health and development: fourth WHO report on neglected tropical diseases

World Health Organization (WHO) (2017) C_WHO

Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I... more

Download (534)

View PDF (435)

Strategy for oral health in South-East Asia, 2013-2020

World Health Organization (WHO), Regional Office for South-East-Asia (2013) C_WHO

Oral diseases are among the most common chronic diseases worldwide and constitute a major public health problem due to the huge health and economic burden on individuals, families, societies, and health care systems. The recent emphasis on the role of determinants of health, common risk factors and ... more

Download (52)

View PDF (89)

WHO Guideline on self-care interventions for health and well-being

World Health Organization WHO (2021) C_WHO

Self-care interventions are among the most promising and exciting new approaches to improve health and well-being, both from a health systems perspective and for people who use these interventions. The World Health Organization (WHO) uses the following working definition of self-care: Self-care i... more

Download (231)

View PDF (444)

Living conditions among People with Disabilities in Swaziland: A national representative study

Arne H Eide & Bhekie Jele SINTEF Technology and Society (2011) C1

This is a report from a National, representative household survey carried out in Swaziland in 2009 – 2010. A large amount of effort has been put into this two‐year exercise until finally we can present the results of the combined efforts. First of all, this is a credit to the Federation of Disab... more

Download (255)

View PDF (158)

Nursing Skills and Procedures - Pocket Guide

Anne Griffin, Patricia A. Potter Elsevir (2015) CC

Mosby’s Pocket Guide to Nursing Skills and Procedures, eighth edition, is a practical, portable reference for students and practitioners in the clinical setting. Grouped alphabetically, 85 commonly performed skills are presented in a clear, step-by-step format that includes: ■ Purpose for pe... more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (212)

View PDF (336)

Evaluation of the Free Diagnostics Scheme in Andhra Pradesh

Ministry of Health & Family Welfare, India World Health Organization WHO, India (2018) C_WHO

Download (899)

View PDF (840)

Namibia: Nutrition guidelines for prevention and management of non-communicable diet related disease

Ministry of Health and Social Services (MOHSS) (2013) C1

Download (555)

View PDF (1358)

Guidelines on Zika Virus Disease following Epidemic in Brazil and other countries of America

National Tuberculosis and Leprosy Programme Ministry of Health and Social Welfare, India (2016) C1

Download (617)

View PDF (1713)

Australian Guidelines for the Prevention of Infection in Health Care 2010

Australian Commission on Safety and Quality in Health Care (ACSQHC) (2010) C1

An Update will be published in late 2018

Download (1135)

View PDF (3229)

Global guidelines on the prevention of surgical site infection. 2nd edition
recommended

World Health Organization WHO (2018) C_WHO

These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences. The 2018 edition of the guidelines includes the re... more

Download (458)

View PDF (803)

Guidelines for Screening and Management of Diabetic Retinopathy

Ophthalmic Services Unit and the Division of Non Communicable Disease (DNCD), Ministry of Health Kenya (2017) C2

Download (202)

View PDF (361)

Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy

World Health Organization WHO (2013) C_WHO

New criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999

Download (123)

View PDF (239)

Out of Step in EECA: TB Policies in 8 Countries in Eastern Europe and Central Asia

Médecins sans Frontières MSF Stop TB Partnership (2017) C1

A survey of prevention, testing and treatment policies and practices

Download (706)

View PDF (1431)

Ethics Guidance for the Implementation of the End TB Strategy

World Health Organization WHO (2017) C_WHO

Global guidelines on the prevention of surgical site infection. 2nd edition recommended

Global guidelines on the prevention of surgical site infection. 2nd edition
recommended